medigraphic.com
Órgano Oficial del Colegio Mexicano de Alergia, Asma e Inmunología Pediátrica y de la Asociación Latinoamericana de Pediatría

2008, Número 1

<< Anterior Siguiente >>

Alerg Asma Inmunol Pediatr 2008; 17 (1)


Inmunodeficiencia variable común. Un enfoque sobre ciertos aspectos de la inmunoprofilaxis activa

Manfredi R, Calza L

Idioma: Español
Referencias bibliográficas: 13
Paginas: 39-42
Archivo PDF: 194.65 Kb.


RESUMEN

Se considera y discute la inmunodeficiencia variable común, como un desorden poco frecuente del sistema inmunitario congénito, a la luz de las futuras y de las ya existentes opciones de inmunización activa, de acuerdo con las evidencias recientes de la investigación y de la bibliografía.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Fischer MB, Wolf HM, Hauber I et al. Activation via the antigen receptor is impaired in T cells, but not in B cells from patients with common variable immunodeficiency. Eur J Immunol 1996; 26: 231-237.

  2. Thon V, Eggenbauer H, Wolf HM et al. Antigen presentation by common variable immunodeficiency (CVID) B cells and monocytes is unimpaired. Clin Exp Immunol 1997; 108: 1-8.

  3. Carsetti R, Rosado MM, Donnanno S et al. The loss of IgM memory B cells correlates with clinical disease in common variable immunodeficiency. J Allergy Clin Immunol 2005; 115: 412-417.

  4. MacLennan C, Dunn G, Huisson AP et al. Failure to clear persistent vaccine-derived neurovirulent Poliovirus infection in an immunodeficient man. Lancet 2004; 363: 1509-1513.

  5. Yang CF, Chen NY, Jorba J et al. Intratypic recombination among lineages of type 1 vaccine-derived Poliovirus emerging during chronic infection of an immunodeficient patient. J Virol 2005; 79: 12623-12634.

  6. Sutter RW, Prevots R. Vaccine-associated paralytic poliomyelitis among immunodeficient persons. Infect Med 1994; 11: 426-438.

  7. Centers for Disease Control and Prevention. Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated Poliovirus vaccine followed by oral Poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practice (ACIP). Morbid Mortal Weekly Report 1997; 46: 1-25.

  8. Kew OM, Sutter RW, Nottay BK et al. Prolonged replication of a type 1 vaccine-derived Poliovirus in an immunodeficient patient. J Clin Microbiol 1998; 36: 2893-2899.

  9. Sewell WA. CCVID patients may not respond to Influenza immunization. Clin Immunol 2005; 114: 210.

  10. Junker AK, Bonilla FA, Sullivan KE. How to feel the flu. Clin Immunol 2004; 112: 219-220.

  11. Edwards E, Razvi S, Cunningham-Rundles C. IgA deficiency: clinical correlates and responses to pneumococcal vaccine. Clin Immunol 2004; 111: 93-97.

  12. Avanzini MA, Bjorkander J, Soderstrom R et al. Qualitative and quantitative analyses of the antibody response elicited by Haemophilus influenzae type B capsular polysaecharide-tetanus toxoid conjugates in adults in IgG subclass deficiencies and frequent infections. Clin Exp Immunol 1994; 96: 54-58.

  13. Barra A, Bremard-Oury C, Bajart A, Griscelli C, Fritzell B, Preud’homme JL. Immunogenicity of Haemophilus influenzae type N capsular polysaccharide and its tetanus toxoid conjugate in patients with recurrent infections or humoral immunodeficiency. Int J Clin Lab Res 1992; 21: 231-234.




2020     |     www.medigraphic.com